Selinexor in combination with standard chemotherapy in patients with advanced or metastatic solid tumors

Overview of attention for article published in Experimental Hematology & Oncology, December 2021

Altmetric Badge

About this Attention Score

Among the highest-scoring outputs from this source (#47 of 298)
Good Attention Score compared to outputs of the same age (74th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

So far, Altmetric has seen 11 X posts from 10 X users, with an upper bound of 4,279 followers.

RT @LabNaing: Selinexor in combination with standard chemotherapy in patients with advanced or metastatic solid tumors: https://t.co/i6jBDJ…

RT @LabNaing: Selinexor in combination with standard chemotherapy in patients with advanced or metastatic solid tumors: https://t.co/i6jBDJ…

RT @LabNaing: Selinexor in combination with standard chemotherapy in patients with advanced or metastatic solid tumors: https://t.co/i6jBDJ…

RT @LabNaing: Selinexor in combination with standard chemotherapy in patients with advanced or metastatic solid tumors: https://t.co/i6jBDJ…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.